QPPV.COM KNOWLEDGE ASSESSMENT

GVP Module VIII: PASS Inspection and Audit Findings

Test your understanding of the concepts covered by GVP Module VIII: PASS Inspection and Audit Findings.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A project tracker marks a PASS as complete, but a regulatory commitment tracker still shows an open obligation. What control weakness is most likely indicated?

The protocol was necessarily scientifically invalid The study and regulatory commitment lifecycles were not reliably reconciled The final report must be discarded The QPPV must personally manage every project milestone

Question 2 of 10 Which situation most clearly represents a significant protocol deviation requiring scientific assessment?

A minor formatting error in a site communication A delayed internal filing that has no effect on study conduct or interpretation Replacement of a data source in a way that may alter population coverage and outcome ascertainment A routine meeting being rescheduled by two days

Question 3 of 10 When a PASS data source changes, which assessment is most appropriate?

Assess only whether the replacement source is less expensive Assume comparability because both sources contain health data Evaluate effects on population coverage, exposure ascertainment, outcomes, missingness and comparability with earlier data Reject the change automatically regardless of its scientific consequences

Question 4 of 10 Which statement best describes appropriate governance of an unplanned statistical analysis?

Unplanned analyses are automatically unacceptable The analysis may be appropriate if the change is justified, its impact is assessed and the departure is transparently reported The change should be omitted from the final report if it improves the result Statistical sophistication eliminates the need to document methodological changes

Question 5 of 10 An inspector asks how a key result in the final PASS report was derived. Which capability best addresses the request?

Providing the final report without supporting analytical records Demonstrating the result's provenance through the analytical dataset, transformation rules and relevant source information Explaining that the CRO performed the calculation and therefore owns the evidence Repeating the entire study from the beginning during the inspection

Question 6 of 10 Why is 'human error' often an inadequate root cause for an un-escalated PASS deviation?

Human error cannot occur in pharmacovigilance processes It does not explain why the system permitted the error to occur or remain undetected It automatically proves that the deviation was intentional It means that no CAPA can be implemented

Question 7 of 10 A protocol amendment changes the outcome definition because the original data source no longer captures the planned variable. What is the most appropriate control response?

Implement the change immediately because data-source limitations are operational matters Reject the amendment because a PASS protocol must never change Assess the scientific and regulatory consequences, document the rationale, obtain required approvals and explain the effect in the analysis and report Delete the original outcome definition from the protocol history to avoid confusion

Question 8 of 10 What is the most appropriate interpretation of a final PASS report that finds no new safety signal?

The study has no further relevance and can be excluded from future pharmacovigilance activities The result is valuable, but residual uncertainty and implications for the RMP, signal management and future evidence should still be assessed The result automatically proves that the suspected association does not exist No regulatory or pharmacovigilance review is needed once the report is approved internally

Question 9 of 10 What is the central concept linking PASS inspection readiness across the study lifecycle?

Maintaining a complete archive of every study-related document Demonstrating traceability and effective control from the safety question through follow-up action Ensuring that no protocol deviations occur during the study Using the same operational checklist for every type of PASS

Question 10 of 10 A PASS evaluating risk-minimisation activities reports that educational materials were distributed to 90% of target healthcare professionals. What conclusion is best supported by this metric alone?

The risk-minimisation measure was clinically effective The target population experienced the intended reduction in risk An implementation or reach objective was achieved, but effectiveness is not established The measure can be removed from the RMP

GVP Module VIII: PASS Inspection and Audit Findings

Cookie Settings